BA
AGN

Bridgewater Advisors’s Allergan Inc AGN Stock Holding History

Bridgewater Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-13,973
Closed -$1.73M – 106
2014
Q1 		$1.73M Sell
13,973
-56
-0.4% -$6.82K 1.74% 21
2013
Q4 		$1.56M Buy
+14,029
New +$1.34M 1.6% 27

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Bridgewater Advisors's AGN Position: Q2 2014 in Review

Bridgewater Advisors sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 13,973 shares — an estimated $1.73M sold.

Bridgewater Advisors first reported a position in AGN in Q4 2013 and held it in 2 quarters. The position peaked at $1.73M in Q1 2014. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • Bridgewater Advisors reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
  • Bridgewater Advisors sold 13,973 Allergan Inc shares in Q2 2014, an estimated $1.73M.
  • Bridgewater Advisors first reported a position in Allergan Inc in Q4 2013 and held it in 2 quarters.
  • Bridgewater Advisors's Allergan Inc position peaked at $1.73M in Q1 2014.
  • 770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on Bridgewater Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.